Results of a randomized phase IIb study estimating overall survival of pralatrexate versus erlotinib in platinum-pretreated NSCLC

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 29; no. 15_suppl; p. 7554
Main Authors:	Patel, J. D., Azzoli, C. G., Weems, G. A., Koutsoukos, A., Zatloukal, P., Kelly, K.
Format:	Journal Article
Language:	English
Published:	20-05-2011
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!